Investigation unit
Service
Universidad Francisco de Vitoria
Pozuelo de Alarcón, EspañaPublications in collaboration with researchers from Universidad Francisco de Vitoria (16)
2022
-
Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation
JACC: Basic to Translational Science, Vol. 7, Núm. 6, pp. 544-560
2021
-
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
European Heart Journal, Vol. 42, Núm. 32, pp. 3063-3073
-
Association of Left Ventricular Systolic Dysfunction among Carriers of Truncating Variants in Filamin C with Frequent Ventricular Arrhythmia and End-stage Heart Failure
JAMA Cardiology, Vol. 6, Núm. 8, pp. 891-901
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy
ACS Nano, Vol. 15, Núm. 6, pp. 10203-10216
-
Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy
Journal of Biological Chemistry, Vol. 297, Núm. 1
-
Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 3, pp. 216-224
2020
-
Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis
Journal of the American College of Cardiology, Vol. 76, Núm. 2, pp. 186-197
-
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene
Circulation: Heart Failure, Vol. 13, Núm. 10, pp. E006832
-
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European Registry
Circulation: Genomic and Precision Medicine, Vol. 13, Núm. 6, pp. E003117
-
Mortality among Referral Patients with Hypertrophic Cardiomyopathy vs the General European Population
JAMA Cardiology, Vol. 5, Núm. 1, pp. 73-80
-
Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy
Heart, Vol. 106, Núm. 17, pp. 1342-1348
2019
2018
-
Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2471-2481
2017
-
Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling
Journal of the American College of Cardiology, Vol. 69, Núm. 4, pp. 423-433
2016
-
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Journal of the American College of Cardiology, Vol. 68, Núm. 22, pp. 2440-2451